Inicio>>Isotope-Labeled Compounds>> Deuterium>>Bepotastine-d6 (besylate)

Bepotastine-d6 (besylate) (Synonyms: Bepotastine besilate-d6)

Catalog No.GC91436

Bepotastina-d6 está destinada para su uso como estándar interno en la cuantificación de bepotastina por GC- o LC-MS.

Products are for research use only. Not for human use. We do not sell to patients.

Bepotastine-d6 (besylate) Chemical Structure

Cas No.: 2469626-71-7

Tamaño Precio Disponibilidad Cantidad
1mg
419,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
Bepotastine-d6 is intended for use as an internal standard for the quantification of bepotastine by GC- or LC-MS. Bepotastine is an antagonist of the histamine H1 receptor that is selective over H3, α1-, α2-, and β-adrenergic, dopamine D2long, serotonin 5-HT2, muscarinic acetylcholine, and benzodiazepine receptors.1 It reduces dye leakage from the nasal passages of rats acutely sensitized to an antigen (ED50 = 0.03 mg/kg) and inhibits histamine-induced bronchoconstriction in the anesthetized dog (ED50 = 3.2 µg/kg).2,3 Bepotastine prevents conjunctival vascular hyperpermeability in a guinea pig model of conjunctivitis in a dose-dependent manner.4 Formulations containing bepotastine have been used in the treatment of itching associated with allergic conjunctivitis.

Reseñas

Review for Bepotastine-d6 (besylate)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Bepotastine-d6 (besylate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.